Pathogenesis of Chronic Chagas Heart Disease

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Circulation

• Publication date

  2007-03-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.106.624296PMID 17339569
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of myocardial damage in Trypanosoma cruzi infection.

  2008cited by this paper
• World Class Parasites: Vol. X, Schistosomiasis

  2006cited by this paper
• TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients.

  2006cited by this paper
• Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients.

  2006cited by this paper
• Induction of cardiac autoimmunity in Chagas heart disease: A case for molecular mimicry

  2006cited by this paper
• The Trypanosoma cruzi–host-cell interplay: location, invasion, retention

  2005cited by this paper
• Does Trypanosoma cruzi calreticulin modulate the complement system and angiogenesis?

  2005cited by this paper
• The impact of HIV infection on tropical diseases.

  2005cited by this paper
• T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain.

  2005cited by this paper
• Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection).

  2005cited by this paper
• Where do we stand on the autoimmunity hypothesis of Chagas disease?

  2005cited by this paper
• Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease.

  2005cited by this paper
• Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients.

  2005cited by this paper
• Myocardiocyte apoptosis in heart failure in chronic Chagas' disease.

  2005cited by this paper
• Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy.

  2005cited by this paper
• Treatment with Benznidazole during the Chronic Phase of Experimental Chagas' Disease Decreases Cardiac Alterations

  2005cited by this paper
• Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: Comparison with myocardial rejection process

  2005cited by this paper
• 35 - Autoimmunity in Chagas' Disease

  2004cited by this paper
• Chagasic enteropathy.

  2004cited by this paper
• Evidence that Development of Severe Cardiomyopathy in Human Chagas' Disease Is Due to a Th1-Specific Immune Response

  2003cited by this paper
• Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients.

  2003cited by this paper
• The Syrian hamster as a model for the dilated cardiomyopathy of Chagas' disease: a quantitative echocardiographical and histopathological analysis.

  2003cited by this paper
• Indeterminate Chagas' disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy.

  2003cited by this paper
• Pathogenesis of chronic chagas heart disease: parasite persistence and autoimmune responses versus cardiac remodelling and neurohormonal activation.

  2002cited by this paper
• Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection.

  2002cited by this paper
• Chemokines, inflammation and Trypanosoma cruzi infection.

  2002cited by this paper
• Genetic Immunization Elicits Antigen-Specific Protective Immune Responses and Decreases Disease Severity in Trypanosoma cruzi Infection

  2002cited by this paper
• Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens.

  2002cited by this paper
• Clinical and epidemiological aspects of Chagas disease.

  2001cited by this paper
• Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease.

  2001cited by this paper
• Parasite persistence in the aetiology of Chagas disease.

  2001cited by this paper
• Cardiac Myosin Autoimmunity in Acute Chagas' Heart Disease

  2001cited by this paper
• The Brazilian experience with heart transplantation: a multicenter report.

  2001cited by this paper
• Neuron count reevaluation in the myenteric plexus of chagasic megacolon after morphometric neuron analysis

  2001cited by this paper
• Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection.

  2001cited by this paper
• A heart‐specific CD4+ T‐cell line obtained from a chronic chagasic mouse induces carditis in heart‐immunized mice and rejection of normal heart transplants in the absence of Trypanosoma cruzi

  2001cited by this paper
• Cruzipain induces autoimmune response against skeletal muscle and tissue damage in mice

  2000cited by this paper
• Immunization with the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins induces long-term duration cross-reactive antibodies with heart functional and structural alterations in young and aged mice.

  2000cited by this paper
• Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives.

  2000cited by this paper
• Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans‐sialidase

  2000cited by this paper
• Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy.

  2000cited by this paper
• Systematic mapping of hearts from chronic chagasic patients: the association between the occurrence of histopathological lesions and Trypanosoma cruzi antigens

  2000cited by this paper
• Influence of Acute-Phase Parasite Load on Pathology, Parasitism, and Activation of the Immune System at the Late Chronic Phase of Chagas’ Disease

  1999cited by this paper
• Reduced [123I]MIBG uptake precedes wall motion impairment in Chagas' disease

  1999cited by this paper
• Parasite persistence correlates with disease severity and localization in chronic Chagas' disease.

  1999cited by this paper
• Myocardial parasite persistence in chronic chagasic patients.

  1999cited by this paper
• Is ibutilide a negative inotrope for the left atrial appendage

  1998cited by this paper
• A CT Study of the Course of Growth of the Maxillary Sinus: Normal Subjects and Subjects with Chronic Sinusitis

  1998cited by this paper
• Chagas' heart disease and the autonomic nervous system.

  1998cited by this paper
• Polymerase chain reaction amplification of three different Trypanosoma cruzi DNA sequences from human chagasic cardiac tissue.

  1998cited by this paper
• Heart autonomic innervation during the acute phase of experimental American trypanosomiasis in the dog.

  1998cited by this paper
• Cardiac autonomic impairment and early myocardial damage involving the right ventricle are independent phenomena in Chagas' disease.

  1998cited by this paper
• The indeterminate phase of Chagas' disease: ultrastructural characterization of cardiac changes in the canine model.

  1997cited by this paper
• Aortic endothelial cell changes in the acute septicemic phase of experimental Trypanosoma cruzi infection in rats: scanning and transmission electron microscopic study.

  1997cited by this paper
• Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications

  1997cited by this paper
• Sudden and unexpected death in clinically 'silent' Chagas' disease. A hypothesis.

  1997cited by this paper
• Etiological treatment for chagas disease—The National Health Foundation of Brazil

  1997cited by this paper
• Molecular mimicry between cardiac myosin and Trypanosoma cruzi antigen B13: identification of a B13-driven human T cell clone that recognizes cardiac myosin.

  1997cited by this paper
• Sera from chronic chagasic patients with complex cardiac arrhythmias depress electrogenesis and conduction in isolated rabbit hearts.

  1997cited by this paper
• In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease.

  1996cited by this paper
• PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease.

  1996cited by this paper
• Trypanosoma cruzi strains and autonomic nervous system pathology in experimental Chagas disease.

  1996cited by this paper
• Antiadrenergic and muscarinic receptor antibodies in Chagas' cardiomyopathy.

  1996cited by this paper
• Preganglionic fibres of the adrenal medulla and cervical sympathetic ganglia: differential involvement during experimental American trypanosomiasis in rats

  1996cited by this paper
• Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient.

  1996cited by this paper
• Autoimmunity in chagas disease cardiomyopathy: Fulfilling the criteria at last?

  1996cited by this paper
• Compromised microcirculation in acute murine Trypanosoma cruzi infection.

  1996cited by this paper
• Characterization of Trypanosoma cruzi populations by zymodemes: correlation with clinical picture.

  1996cited by this paper
• Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1- adrenergic receptor

  1995cited by this paper
• Functional alterations of the autonomic nervous system in Chagas' heart disease

  1995cited by this paper
• Coronary vascular reactivity is abnormal in patients with Chagas' heart disease.

  1995cited by this paper
• Functional alterations of the autonomic nervous system in Chagas' heart disease.

  1995cited by this paper
• Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen.

  1995cited by this paper
• Studies of the coronary circulation in Chagas' heart disease.

  1995cited by this paper
• Effects of immunosuppression and benzonidazole on Trypanosoma cruzi parasitism during experimental acute Chagas' disease.

  1994cited by this paper
• Myocardial changes in acute Trypanosoma cruzi infection. Ultrastructural evidence of immune damage and the role of microangiopathy.

  1994cited by this paper
• [Detection of myocardial ischemia in chronic Chagas disease patients with atypic precordial pain by exercise and Holter tests].

  1993cited by this paper
• Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: Light microscopy and immunohistochemical findings.

  1993cited by this paper
• Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy.

  1993cited by this paper
• Trypanosoma cruzi: alteration of cAMP metabolism following infection of human endothelial cells.

  1992cited by this paper
• Myocardial perfusion abnormalities in chronic Chagas' disease as detected by thallium-201 scintigraphy.

  1992cited by this paper
• [The evolution of chronic chagasic cardiopathy. I. The influence of parasitemia].

  1992cited by this paper
• Impaired heart rate variability in patients with chronic Chagas' disease.

  1991cited by this paper
• Abnormal baroreflex control of heart rate in decompensated congestive heart failure and reversal after compensation.

  1991cited by this paper
• Reversibility of cardiac fibrosis in mice chronically infected with Trypanosoma cruzi, under specific chemotherapy.

  1991cited by this paper
• Chagas' heart disease in the United States.

  1991cited by this paper
• Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy.

  1990cited by this paper
• Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease.

  1990cited by this paper
• Pathophysiological insights into the cardiomyopathy of Chagas' disease.

  1990cited by this paper
• Intensification of acute Trypanosoma cruzi myocarditis in BALB/c mice pretreated with low doses of cyclophosphamide or gamma irradiation.

  1990cited by this paper
• Experimental carditis induced by Trypanosoma cruzi (y strain) in guinea pigs: correlation between histopathology and the presence of T. cruzi antigens identified by indirect immunofluorescence

  1990cited by this paper
• Verapamil ameliorates clinical, pathologic and biochemical manifestations of experimental chagasic cardiomyopathy in mice.

  1989cited by this paper
• The indeterminate form of human chronic Chagas' disease A clinical epidemiological review.

  1989cited by this paper
• Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization.

  1989cited by this paper
• Autoimmunity in Chagas' disease: specific inhibition of reactivity of CD4+ T cells against myosin in mice chronically infected with Trypanosoma cruzi

  1989cited by this paper
• Basement membrane thickening in cardiac myocytes and capillaries in chronic Chagas' disease.

  1988cited by this paper
• Persistence of Trypanosoma cruzi antigens in the inflammatory lesions of chronically infected mice.

  1988cited by this paper
• [Radionuclide angiocardiographic evaluation of the effect of isosorbide dinitrate in patients with Chagas' disease].

  1988cited by this paper
• Autoimmunity in Chagas' disease.

  1987cited by this paper
• Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of cyclophosphamide.

  1987cited by this paper

• Prevalence of atrial fibrillation and conduction abnormalities in Chagas disease: a systematic review and an updated meta-analysis.

  2026cites this paper
• Association between circulating microRNAs and Chagas cardiomyopathy: A meta-analysis.

  2026cites this paper
• Acute Myocarditis and Inflammatory Cardiomyopathies: Insights From Cardiac Magnetic Resonance Findings

  2025cites this paper
• Effects of pentoxifylline in patients with chronic Chagas cardiomyopathy: A randomized, double-blind, controlled pilot trial

  2025cites this paper
• Decreased Insulin Levels in Patients with Acute Chagas Disease from Brazilian Amazon treated with Benznidazole

  2025cites this paper
• Profile of soluble cell adhesion molecules as potential biomarkers in the cardiac stages of chronic Chagas disease

  2025cites this paper
• Cardiovascular outcomes of chagas-induced non-ischemic cardiomyopathy versus other nonischemic cardiomyopathies: a regression matched national cohort analysis.

  2025cites this paper
• Heart rate variability derangements in dogs with Chagas disease: a potential indicator of autonomic and cardiac disruption.

  2025cites this paper
• Galectin-8 deficiency promotes chronic splenomegaly persistence in Chagas disease

  2025cites this paper
• Acute Heart Failure in Patients with Chagas Cardiomyopathy: Results of the I Brazilian Heart Failure Registry (BREATHE).

  2025cites this paper
• Redução dos Níveis de Insulina em Pacientes com Doença de Chagas Aguda na Amazônia Brasileira Tratados com Benznidazol

  2025cites this paper
• Evaluation of Cardiac IL-11 and IL-11Rα Expression During T. cruzi Infection

  2025cites this paper
• Beyond Trypanosoma cruzi: LINE-1 Activation as a Driver of Chronic Inflammation in Chagas Disease

  2025cites this paper
• The distinct functions of MIF in inflammatory cardiomyopathy

  2025cites this paper
• System-based insights into parasitological and clinical treatment failure in Chagas disease

  2025cites this paper
• An Update on Vaccines Against Trypanosoma cruzi and Chagas Disease

  2025cites this paper
• Self and parasite-derived peptides selected upon DERAA-bearing HLA-DRB1 alleles activate CD4+ T cells from Chagas cardiomyopathy patients and are associated with ventricular dysfunction

  2025cites this paper
• Immunologic changes in the peripheral blood transcriptome of individuals with early-stage chronic Chagas cardiomyopathy: a cross-sectional study

  2025cites this paper
• Parasitic infections and the development of endomyocardial fibrosis: systematic review of case reports and case series

  2025cites this paper
• Bridging the Nervous-Endocrine System and Immune Response, in Human Chagas Disease Pathology

  2025cites this paper
• Nasal vaccination against Trypanosoma cruzi: a dual approach for prevention and treatment of chronic Chagas cardiomyopathy

  2025cites this paper
• Clinical and Epidemiological Profile of Heart Failure Patients with Chagas Disease: Insights from the SEPE-HF Registry.

  2025cites this paper
• Cardiac Conduction Disorders Due to Acquired or Genetic Causes in Young Adults: A Review of the Current Literature

  2025cites this paper
• II – Evaluation of Autonomic Control of Heart Rate in Various Clinical Conditions

  2025cites this paper
• People with heart failure, sarcopenia and chagas disease: A systematic review and meta-analysis

  2025cites this paper
• New parameter for QRS complex low voltage in chagasic cardiomyopathy: the ADOC index

  2025cites this paper
• Revisión de la enfermedad de Chagas en pacientes pediátricos. Presentación de un caso clínico

  2025cites this paper
• Role of glucocorticoid receptor expression in Chronic Chagas Cardiomyopathy: implications for inflammation and cardiac hypertrophy

  2025cites this paper
• II - Evaluation of Autonomic Control of Heart Rate in Various Clinical Conditions.

  2025cites this paper
• Exploring Peripheral Blood-Derived Extracellular Vesicles as Biomarkers: Implications for Chronic Chagas Disease with Viral Infection or Transplantation

  2024cites this paper
• Brazilian Guideline for Exercise Test in the Adult Population – 2024

  2024cites this paper
• Impact of antiparasitic therapy on cardiovascular outcomes in chronic Chagas disease. A systematic review and meta-analysis

  2024cites this paper
• The Functions of Cytokines in the Cardiac Immunopathogenesis of Chagas Disease

  2024cites this paper
• Unraveling the Missing Pieces: Exploring the Gaps in Understanding Chagas Cardiomyopathy

  2024influential citation
• Treinamento Físico Reduz a Inflamação e a Fibrose e Preserva a Função e a Perfusão Miocárdica em um Modelo de Cardiomiopatia Chagásica Crônica

  2024cites this paper
• Chagas cardiomyopathy in Boston, Massachusetts: Identifying disease and improving management after community and hospital-based screening

  2024cites this paper
• Machine learning, molecular docking and simulation studies reveal Lomitapide, Lodipamide, Zafirlukast, Netupitant and Salmon Calcitonin as potent drug molecules against Chagas disease

  2024cites this paper
• Chagas Disease: A Silent Threat for Dogs and Humans

  2024cites this paper
• Arrhythmogenic Left Ventricular Cardiomyopathy: From Diagnosis to Risk Management

  2024cites this paper
• INFLUENCE OF ESOPHAGEAL MOTILITY IMPAIRMENT ON UPPER AND LOWER ESOPHAGEAL SPHINCTER PRESSURE IN CHAGAS DISEASE.

  2024cites this paper
• Chagas Cardiomyopathy and Myocardial Sympathetic Denervation

  2024cites this paper
• Cardiac involvement in Chagas disease and African trypanosomiasis

  2024cites this paper
• Arrhythmogenic Manifestations of Chagas Disease: Perspectives From the Bench to Bedside

  2024cites this paper
• Echocardiographic Documentation of Dilated Cardiomyopathy Development in Dogs Naturally Infected with Trypanosoma cruzi

  2024cites this paper
• Metabolomic insights in advanced cardiomyopathy of chronic chagasic and idiopathic patients that underwent heart transplant

  2024cites this paper
• Mortality risk score for patients with Chagas cardiomyopathy and pacemaker

  2024cites this paper
• Association of Sympathetic Denervation, Myocardial Hypoperfusion, and Fibrosis with Ventricular Arrhythmias in Chronic Chagas Cardiomyopathy

  2024cites this paper
• Associação Entre Denervação Simpática, Hipoperfusão Miocárdica e Fibrose com as Arritmias Ventriculares na Cardiopatia Chagásica Crônica

  2024cites this paper
• Mechanisms behind the high mortality rate in chronic Chagas cardiomyopathy: Unmasking a three‐headed monster

  2024cites this paper
• Molecular similarities between the genes for Trypanosoma cruzi microtubule-associated proteins, mammalian interferons, and TRIMs

  2024cites this paper
• The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis

  2024cites this paper
• Beyond the acute phase: a comprehensive literature review of long-term sequelae resulting from infectious diseases

  2024cites this paper
• Impact of cardiac structure and function on exercise intolerance in Chagas cardiomyopathy: Insights from CPET and echocardiography.

  2024cites this paper
• Exercise Training Reduces Inflammation and Fibrosis and Preserves Myocardial Function and Perfusion in a Model of Chronic Chagas Cardiomyopathy

  2024influential citation
• Diretriz Brasileira de Ergometria em População Adulta – 2024

  2024cites this paper
• Sublingual microcirculatory alterations in Chagas disease: an observational study in an endemic rural population

  2024cites this paper
• Ventricular tachycardia in Chagas disease patients: Our worst nightmare

  2024cites this paper
• SUBCELLULAR PARTICLES for CHARACTERIZATION of HOST-PARASITE INTERACTIONS.

  2024cites this paper
• Inspiratory Muscle Strength in Chagas Cardiomyopathy: A Systematic Scoping Review

  2023cites this paper
• Exploring the Historical Background and Clinical Implications of Electrocardiogram in the Context of Chagas Disease Research

  2023cites this paper
• Dynamics of Trypanosoma cruzi infection in hamsters and novel association with progressive motor dysfunction

  2023cites this paper
• Vagal dysautonomia in patients with Chagas disease and mortality: 14-year results of a population cohort of the elderly.

  2023cites this paper
• Ten years follow-up of the largest oral Chagas disease outbreak: Cardiological prospective cohort study

  2023cites this paper
• Immunologic changes are detectable in the peripheral blood transcriptome of clinically asymptomatic Chagas cardiomyopathy patients

  2023cites this paper
• Signature of cardiac alterations in early and late chronic infections with Trypanosoma cruzi in mice

  2023cites this paper
• Chagas disease treatment efficacy markers: experiences from a Phase III study with nifurtimox in children

  2023cites this paper
• Localized cardiac small molecule trajectories and persistent chemical sequelae in experimental Chagas disease

  2023influential citation
• Differential expression profile of genes involved in the immune response associated to progression of chronic Chagas disease

  2023cites this paper
• State‐of‐the‐art document on optimal contemporary management of cardiomyopathies

  2023cites this paper
• Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas – 2023

  2023cites this paper
• Characterization of Patients with Heart Failure of Chagas Etiology in Colombia: An Analysis Based on the Colombian Registry of Heart Failure (RECOLFACA).

  2023cites this paper
• cGAS-STING Pathway Activation during Trypanosoma cruzi Infection Leads to Tissue-Dependent Parasite Control.

  2023cites this paper
• Current vision of a disease with high mortality that is progressively dispersing throughout the world: Chagasic heart disease

  2023cites this paper
• WHF Recommendations for the Use of Echocardiography in Chagas Disease

  2023cites this paper
• Autonomic denervation, myocardial hypoperfusion and fibrosis may predict ventricular arrhythmia in the early stages of Chagas cardiomyopathy

  2023cites this paper
• Pentoxifylline reduces inflammation and prevents myocardial perfusion derangements in experimental chronic Chagas’ cardiomyopathy

  2023cites this paper
• Hallmarks of the relationship between host and Trypanosoma cruzi sulfated glycoconjugates along the course of Chagas disease

  2023cites this paper
• Myocarditis: Etiology, Pathogenesis, and Their Implications in Clinical Practice

  2023cites this paper
• Coronary microvascular dysfunction due to Chagas disease: where are we now?

  2023influential citation
• Risk Factors for Progression to Chronic Chagas Cardiomyopathy: A Systematic Review and Meta-Analysis.

  2023cites this paper
• Trypanosoma cruzi dysregulates expression profile of piRNAs in primary human cardiac fibroblasts during early infection phase

  2023cites this paper
• Targeting regulatory T cells for cardiovascular diseases

  2023influential citation
• Immunopathological Mechanisms Underlying Cardiac Damage in Chagas Disease

  2023cites this paper
• Sudden cardiac death multiparametric classification system for Chagas heart disease's patients based on clinical data and 24-hours ECG monitoring.

  2023cites this paper
• Development and Application of an Assay to Evaluate the Anti-Parasitic Effect of Humoral Responses against Trypanosoma cruzi

  2023cites this paper
• Diretriz Brasileira de Dispositivos Cardíacos Eletrônicos Implantáveis – 2023

  2023cites this paper
• Localized cardiac metabolic trajectories and post-infectious metabolic sequelae in experimental Chagas disease

  2023cites this paper
• Structural Modelling of Platelet Activating Factor Acetyl Hydrolase in Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei: Implications on Therapeutics for Leishmaniasis, Chagas Disease, and Sleeping Sickness

  2023cites this paper
• Main Cardiac Histopathologic Alterations in the Acute Phase of Trypanosoma cruzi Infection in a Murine Model

  2023cites this paper
• Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease

  2023cites this paper
• Chronic Chagas Disease—the Potential Role of Reinfections in Cardiomyopathy Pathogenesis

  2022cites this paper
• Epicardial mapping complicated by multi-vessel coronary spasm and electrical storm

  2022cites this paper
• In vitro interaction of polyethylene glycol-block-poly(D,L-lactide) nanocapsule devices with host cardiomyoblasts and Trypanosoma cruzi-infective forms

  2022cites this paper
• Call for Consensus in the Evaluation of Circulating Matrix Metalloproteinases in Chagas Disease

  2022cites this paper
• Relação entre Norepinefrina Urinária, Fibrose e Arritmias na Cardiopatia Chagásica Crônica com Fração de Ejeção Preservada ou Minimamente Reduzida

  2022cites this paper
• Core Proteomics and Immunoinformatic Approaches to Design a Multiepitope Reverse Vaccine Candidate against Chagas Disease

  2022cites this paper
• Efficacy and Safety of Granulocyte-Colony Stimulating Factor Therapy in Chagas Cardiomyopathy: A Phase II Double-Blind, Randomized, Placebo-Controlled Clinical Trial

  2022cites this paper
• Preclinical advances and the immunophysiology of a new therapeutic Chagas disease vaccine

  2022cites this paper
• Pathophysiology and new targets for therapeutic options in Chagas heart disease

  2022cites this paper
• Prognosis of chronic Chagas heart disease and other pending clinical challenges

  2022cites this paper